Ключевые слова:
эндометриоид полип, Ki67, иммуногистокимё, пролиферация, беғуворлик, безли тўқима.Библиографические ссылки
Amin M.B., et al. WHO classification of tumors: female genital tract tumors. – 2020.
Babayeva N.M. The significance of the Ki67 marker in assessing endometrial proliferation // Russian Journal of Gynecology. - 2021.
Khudoyberdiyeva Sh.R. Immunohisto-che-mical study of Ki67 in endometrial hyperplasia // Bulletin of Biomedicine. - 2022.
Kim J.J., Chapman-Davis E. Role of proges-terone in endometrial cancer // Semin Reprod Med. – 2021.
Nurkhanova Nilufar Odilovna. Vitamin D level and metabolic disorders in patients with endometrial hyperplasia in the perimenopausal period // American journal of medicine and medical sciences. 2024, 14 (5) - P. 1365-1368. http://article.sapub.org/10.5923.j.ajmms.20241405.47.html.
Nurkhanova N.O. Аssessment of the risk of endometrial hyperplasia in the perimenopausal period. / International Journal of Advanced Research in Engineering and Applied Sciences, 2022. Vol. 11. No. 6. Р. 8-15. https://garph.co.uk/IJAREAS/June 2022/2.pdf.
Mittal K. et al. Ki-67 as a proliferation mar-ker in gynecologic neoplasia // Arch Pathol Lab Med. – 2020.